Browse by:
Research & Development

WPI researchers develop 'sperm sorting' device

A group of researchers at Worcester Polytechnic Institute and Stanford University have developed a device that selects faster, healthier sperm to be used during in vitro fertilization.

RXi scarring treatment trial yields positive results

Emily Micucci |

RXi Pharmaceuticals, a clinical-stage drug company based in Marlborough, announced positive results from a clinical trial of its lead drug candidate, RXI-109.

Biostage scores $4M private investment, eyes turnaround

Zachary Comeau |

Two months after laying off more than 70 percent of its workforce and being delisted from Nasdaq, Holliston biotech Biostage announced on Thursday a $4-million private investment.

Study: Hospital ERs need improvement in treating older adults with cancer

Emily Micucci |

A new study finds older adults with cancer are more likely than those without cancer to be admitted from the emergency department.

SCIEX appoints new president

Emily Micucci |

Life sciences analystics technology firm SCIEX announced last week the appointment of Inese Lowenstein as the Framingham-based company's new president.

UMMS panel to call for protection of NIH funding

Emily Micucci |

Congressman James McGovern and others will call on Congress and the White House not to cut National Institutes of Health funding for critical medical research in a panel discussion today.

Biostage completes successful human implant

Emily Micucci |

Holliston-based Biostage Inc. on Monday announced the first implant of its proprietary Cellspan Esophageal Implant in a human patient.

Veristat managing new clinical trial

Emily Micucci |

Southborough-based Veristat is overseeing a new immunotherapy clinical trial for patients with ovarian cancer.

Copyright 2017 New England Business Media